Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma
Cetuximab can be used for the treatment of advanced basal cell carcinoma, especially when the patient cannot tolerate routine chemotherapy. Future studies are needed to confirm it. AbstractCetuximab can be used for the treatment of advanced basal cell carcinoma, especially when the patient cannot tolerate routine chemotherapy. Future studies are needed to confirm it.
Source: Clinical Case Reports - Category: General Medicine Authors: Amir Amirabadi,
Amirhosein Alami,
Hamid Ahanchian,
Nazila Ariaee,
Nasrin Moazzen Tags: CASE REPORT Source Type: research
More News: Basal Cell Carcinoma | Cancer & Oncology | Carcinoma | Chemotherapy | Erbitux | General Medicine | Skin Cancer | Study